MedPath

Aromatherapy to Reduce Pain and Anxiety During Cervical Colposcopy

Not Applicable
Completed
Conditions
Colposcopy
Interventions
Other: Lavender Scent
Other: Essential Lavender Oil
Registration Number
NCT01214304
Lead Sponsor
Mike O'Callaghan Military Hospital
Brief Summary

The purpose of this study is to determine whether aromatherapy with lavender oil compared to placebo lowers anxiety levels in women during colposcopy.

Detailed Description

Aromatherapy is a modality that might reduce anxiety. Women experience high levels of anxiety and negative emotional responses at all stages of cervical cancer screening. High levels of anxiety before and during colposcopy can be bad. If lavender oil aromatherapy reduces anxiety, then simple use of this modality may improve experiences during colposcopy.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
262
Inclusion Criteria
  • Tricare Insurance Beneficiary (military insurance) receiving care at Nellis AFB
  • All women at least 18 yrs of age undergoing colposcopy who have not previously participated in this protocol.
Exclusion Criteria
  • age <18 years
  • pregnancy
  • breastfeeding
  • asthma
  • poor sense of smell
  • allergy to one of the essential oils
  • consumption of any analgesic
  • short-term anxiolytic (i.e. benzodiazepines) or chronic anxiolytic medications (i.e. SSRI)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Lavender ScentLavender ScentPatients will receive aromatherapy with a fake lavender scent (placebo) which will be initiated 5 minutes prior to the procedure and continued until the conclusion of the procedure.
Essential Lavender OilEssential Lavender OilPatients will receive essential Lavender Oil which will be initiated 5 minutes prior to the procedure and continued until the conclusion of the procedure.
Primary Outcome Measures
NameTimeMethod
Pain Level8 months

Patients will be measured on an 11 point scale from 0 to 10 on their pain Level.

Secondary Outcome Measures
NameTimeMethod
Anxiety Level8 months

Patients will be measured on an 11 point scale from 0 to 10 on their anxiety level.

Trial Locations

Locations (1)

Mike O'Callaghan Federal Medical Center

🇺🇸

Las Vegas, Nevada, United States

© Copyright 2025. All Rights Reserved by MedPath